Dr. Adnan Z. Rizvi, MD

Dr. Rizvi practices at Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington.

Dr. Rizvi's NPI, 1669482154, was assigned on August 8, 2006. Dr. Rizvi graduated from New York Medical College in 2000. Dr. Rizvi holds Washington license MD60539899.

Dr. Rizvi's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch, at 101 W 8th Ave, Spokane, WA 99204. The practice phone is (509) 474-7370.

Dr. Rizvi's primary practice is Incyte Pathology - Sacred Heart Medical Center Branch in Spokane, Washington. Dr. Rizvi is also affiliated with Prov Sacred Hrt Med Ctr & Childs Hosp. The medical group on file is Providence Medical Group. Dmand AI also links Dr. Rizvi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Rizvi is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Rizvi's licenses on file in 5 states: Washington, Oregon, Montana, Minnesota and Pennsylvania.

Dmand AI lists amputation, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Rizvi treats.

CMS data shows 960 Medicare services from Dr. Rizvi across 16 procedure codes in 2024, for 447 Medicare patients. Medicare paid $100,558 for them.

CMS counts 447 Medicare patients who saw Dr. Rizvi in 2024. The largest group is 75 to 84, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 71, with 43% women.

In 2024, Dr. Rizvi wrote 75 Medicare Part D claims for 41 patients. 96% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $300 in total drug cost. In 2023, CMS named 32 claims across 1 drug.

Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rizvi as offering telehealth. CMS counts 20 procedures of leg revascularization (restoring blood flow) by Dr. Rizvi, more than 80% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 28 papers to Dr. Rizvi, published from 2006 to 2015. 2015 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Postoperative Complications and Blood Vessel Prosthesis Implantation. Dr. Rizvi has published most often in J Vasc Surg. Dr. Rizvi's most frequent co-authors are Peter Brown Alden, MD, Mohammad Hassan Murad, MD and Jason Q. Alexander, MD.

CMS Open Payments shows 248 general payments to Dr. Rizvi from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Silk Road Medical, Inc. paid the most, $25,157.

Dmand AI lists 2 awards for Dr. Rizvi, most recently CMS Stage 1 EHR in 2013.

Dr. Rizvi graduated from New York Medical College in 2000. Dr. Rizvi is a member of AOA, ACS and SVS.

Dr. Rizvi is in network with 15 carriers, including Aetna, United Healthcare and Cigna. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.